Related Experiment Videos
Heparin neutralizing activity and coronary artery disease
Insights
Men with coronary artery disease exhibit slower disaggregation of adenosine diphosphate (ADP)-induced platelet aggregates. This impaired platelet function is linked to the release of heparin neutralizing activity (HNA) from platelets.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Biochemistry
Background:
- Platelet aggregation plays a crucial role in thrombosis and hemostasis.
- Dysfunctional platelet activity is implicated in the pathophysiology of coronary artery disease (CAD).
- The process of platelet aggregate disaggregation is not fully understood, particularly in disease states.
Purpose of the Study:
- To investigate the rate of adenosine diphosphate (ADP)-induced platelet aggregate disaggregation in men with and without coronary artery disease (CAD).
- To determine the relationship between platelet heparin neutralizing activity (HNA) release and the rate of platelet disaggregation.
- To explore potential mechanisms underlying impaired platelet function in CAD.
Main Methods:
- Studied ADP-induced platelet aggregation and disaggregation in platelet-rich plasma (PRP) from 32 men.
- Categorized participants into groups with and without CAD (21 with, 11 without).
- Measured the release of HNA from platelets during aggregation and correlated it with disaggregation rates.
Main Results:
- Slower platelet aggregate disaggregation (<10%) was observed more frequently in men with CAD.
- Platelets from men with slow disaggregation released significantly higher amounts of HNA (34-51%) compared to those with rapid disaggregation.
- A second phase of aggregation, with reduced light transmission, was noted in most PRP samples with rapid disaggregation.
Conclusions:
- Impaired disaggregation of ADP-induced platelet aggregates is more common in men with CAD.
- The release of HNA from platelets during aggregation may contribute to the inhibition of disaggregation.
- These findings suggest a potential role for HNA in the altered platelet dynamics observed in coronary artery disease.
Abstract:
It has been previously shown and confirmed in the present investigation that the disaggregation of adenosine diphosphate (ADP)-induced platelet aggregates occurs at a slow rate more frequently in the platelet-rich plasma (PRP) of men with coronary artery disease. ADP-induced platelet aggregation was studied in the citrated PRP of 32 men (21 with and 11 without coronary artery disease) to determine the relation between release of heparin neutralizing activity (HNA) from platelets and the rate of platelet diaggregation. Each of the five PRP with slow (less than 10 per cent) disaggregation were from men with coronary artery disease. Platelets from these five PRP released from 34 to 51 per cent of their content of HNA during ADP-induced aggregation in contrast to the 27 PRP with more rapid disaggregation, only three of which had a detectable release of HNA. Of the latter 27 PRP, 21 had a second phase of aggregation which usually reached a peak of light transmission less than that of the first phase. These data are consistent with (but do not prove) the hypothesis that HNA released during aggreation may be one of the factors tending to prevent disaggregation of ADP-induced platelet aggregates.